{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00376",
      "entity_text" : "NIH45-46m2 variant",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00309",
      "entity_text" : "IgL",
      "features" : [ {
        "to_base" : "S",
        "site" : 28,
        "feature_type" : "mutation",
        "evidence" : "S28Y"
      } ],
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Neutralization breadth of NIH45-46 W was further extended by adding in the antibody 's CDR L 1 loop the IgL S28Y mutation, which enables the NIH45-46m2 variant (m2) to interact with the gp120 N276 -attached glycan (XREF_FIG A).",
  "reading_complete" : "2020-08-09T05:47:02Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T05:45:00Z",
  "trigger" : "enables",
  "evidence" : [ "IgL S28Y  mutation, which enables the NIH45-46m2 variant" ],
  "pmc_id" : "5990490",
  "score" : 0
}